Codexis, Inc. CDXS
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $8.00 (+446.1% upside)
Key Stats
- Today's Range
- $1.43 – $1.48
- 50-Day Range
- $1.38 – $2.69
- 52-Week Range
- $0.96 – $3.87
- Volume
- 505K shs
- Average Volume
- 1.01 million shs
- Market Cap
- $160.43 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 4.87
- Price / Sales
- 2.07
Short Interest
- Short Interest
- 2.11%
- Days to Cover
- 9.01
Financials (TTM)
- Revenue
- $77.68 million
- Net Income
- $-30,723,000
- Net Margin
- -39.55%
- Return on Equity
- -93.22%
- Debt-to-Equity
- 1.24
About Codexis, Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Related Stocks
Compare head-to-head: CDXS vs IFF·CDXS vs ALTO·CDXS vs LODE·CDXS vs TOMZ
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.